Your browser doesn't support javascript.
loading
Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer.
Garside, Jamie; Shen, Qin; Westermayer, Bernd; van de Ven, Michiel; Kroep, Sonja; Chirikov, Viktor; Juhasz-Böss, Ingolf.
Affiliation
  • Garside J; Department of Value Evidence and Outcomes, GSK, London, United Kingdom. Electronic address: jamie.x.garside@gsk.com.
  • Shen Q; Department of Value Evidence and Outcomes, GSK, Collegeville, Pennsylvania.
  • Westermayer B; Department of Biostatistics & Epidemiology, GSK, Munich, Germany.
  • van de Ven M; OPEN Health, Evidence and Access, Rotterdam, The Netherlands.
  • Kroep S; OPEN Health, Evidence and Access, Rotterdam, The Netherlands.
  • Chirikov V; OPEN Health, Evidence & Access, Bethesda, Maryland.
  • Juhasz-Böss I; Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Freiburg, Germany.
Clin Ther ; 45(10): 983-990, 2023 10.
Article in En | MEDLINE | ID: mdl-37689551
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Ther Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Ther Year: 2023 Document type: Article